Tag Archives: JRC

Lancaster, PA, & Rockville, MD May 2, 2012 – Immunomic Therapeutics, Inc., (“ITI,” Lancaster, PA) a privately-held biotechnology company with laboratories in Rockville, MD, announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational … Continue reading →